Summary

a tele-health clinic focused on the science of living longer and better. Their modern men's health platform offers personalized care with data driven insights, licensed physician consultations, and medications, all from home.

Background

Hone Health’s platform started by helping the thousands of men in the US suffering from hypogonadism (low testosterone). Low testosterone is a massive problem, with otherwise healthy males experiencing very low testosterone, even after accounting for their age (). Further, Hone has proven its ability to expand into other categories to address aging, weight loss, energy, brain function, and erectile dysfunction. Hone’s longevity and hypogonadism treatments include guidance from a licensed physician and clinical treatment protocols.

Why Cashmere Fund Invested:

Massive problem without great alternatives:

Men are waking up to the fact that their generation has far lower testosterone levels than previous generations. T-level testing and therapy have in recent years, and men are taking ownership of their health and personal routines in new ways. Hone Health offers a safer and more convenient alternative to the thousands of small, locally managed men’s health clinics that have sprung up across the country to address the problem.

Fast growth with platform potential:

Our team is excited about the early success Hone has seen with revenue growth of 4x in 2021 and 2x in 2022. Further, they reached profitability in 2023 while still experiencing impressive growth in their core and longevity products.